Impact of Anti-Drug Antibodies and Neutralising Antibodies on Safety and Efficacy of Ozoralizumab in Rheumatoid Arthritis
ABSTRACT Objectives To evaluate the induction of antidrug antibodies (ADA) and the expression of neutralising antibodies (NAb) during ozoralizumab treatment, a trivalent anti-TNFα NANOBODY® compound for rheumatoid arthritis, and their impact on safety and efficacy. Methods Data…